m+Medelevator.RU
← Поиск публикаций
Urology · 2012

Transumbilical multiport laparoscopic orchiopexy in children: comparison with standard laparoscopic orchiopexy.

Сравнительное исследованиеСтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Mei Hong, Pu Jiarui, Qi Teng, Qi Meng, Li Dan, Tang Shaotao, Zheng Liduan, Tong Qiangsong

Аннотация

OBJECTIVE: To compare the clinical outcomes of transumbilical multiport laparoscopic orchiopexy (TMLO) vs standard laparoscopic orchiopexy (SLO) for 1-stage management of impalpable testes in children.

MATERIALS AND METHODS: A total of 30 patients underwent primary TMLO from January 2010 to December 2011. An additional 25 patients underwent SLO during the same period. These 2 procedures were performed with 3 ports and the usual laparoscopic instruments. The demographic, intraoperative, postoperative, and follow-up data were analyzed and compared between the patients.

RESULTS: The patients' demographic data were similar between the 2 groups. The mean operative time was slightly longer in the TMLO than in the SLO group (54.2 vs 47.3 minutes, P <.05), without intraoperative complications in either group. However, no significant difference was noted between the TMLO and SLO groups in the length of hospital stay (4.0 vs 4.1 days, P >.05), interval to resume feeding (5.2 vs 5.4 hours, P >.05) or full activity (2.1 vs 2.2 days, P >.05), viable testis rate (33 of 34 vs 27 of 28, P >.05), or testicular atrophy (1 of 34 vs 1 of 28, P >.05).

CONCLUSION: TMLO is a feasible and safe procedure for the management of impalpable testes in children, with clinical outcomes similar to those of SLO. Future randomized studies with a larger number of patients and longer follow-up are warranted to elucidate the benefits and limitations of TMLO in children.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты